Gut microbiota disturbance during antibiotic therapy: a multi-omic approach
Ana Elena Pérez-Cobas, María José Gosalbes, Anette Friedrichs, Henrik Knecht, Alejandro Artacho, Kathleen Eismann, Wolfgang Otto, David Rojo, Rafael Bargiela, Martin von Bergen, Sven C Neulinger, Carolin Däumer, Femke-Anouska Heinsen, Amparo Latorre, Coral Barbas, Jana Seifert, Vitor Martins dos Santos, Stephan J Ott, Manuel Ferrer, Andrés Moya, Ana Elena Pérez-Cobas, María José Gosalbes, Anette Friedrichs, Henrik Knecht, Alejandro Artacho, Kathleen Eismann, Wolfgang Otto, David Rojo, Rafael Bargiela, Martin von Bergen, Sven C Neulinger, Carolin Däumer, Femke-Anouska Heinsen, Amparo Latorre, Coral Barbas, Jana Seifert, Vitor Martins dos Santos, Stephan J Ott, Manuel Ferrer, Andrés Moya
Abstract
Objective: Antibiotic (AB) usage strongly affects microbial intestinal metabolism and thereby impacts human health. Understanding this process and the underlying mechanisms remains a major research goal. Accordingly, we conducted the first comparative omic investigation of gut microbial communities in faecal samples taken at multiple time points from an individual subjected to β-lactam therapy.
Methods: The total (16S rDNA) and active (16S rRNA) microbiota, metagenome, metatranscriptome (mRNAs), metametabolome (high-performance liquid chromatography coupled to electrospray ionisation and quadrupole time-of-flight mass spectrometry) and metaproteome (ultra high performing liquid chromatography coupled to an Orbitrap MS(2) instrument [UPLC-LTQ Orbitrap-MS/MS]) of a patient undergoing AB therapy for 14 days were evaluated.
Results: Apparently oscillatory population dynamics were observed, with an early reduction in Gram-negative organisms (day 6) and an overall collapse in diversity and possible further colonisation by 'presumptive' naturally resistant bacteria (day 11), followed by the re-growth of Gram-positive species (day 14). During this process, the maximum imbalance in the active microbial fraction occurred later (day 14) than the greatest change in the total microbial fraction, which reached a minimum biodiversity and richness on day 11; additionally, major metabolic changes occurred at day 6. Gut bacteria respond to ABs early by activating systems to avoid the antimicrobial effects of the drugs, while 'presumptively' attenuating their overall energetic metabolic status and the capacity to transport and metabolise bile acid, cholesterol, hormones and vitamins; host-microbial interactions significantly improved after treatment cessation.
Conclusions: This proof-of-concept study provides an extensive description of gut microbiota responses to follow-up β-lactam therapy. The results demonstrate that ABs targeting specific pathogenic infections and diseases may alter gut microbial ecology and interactions with host metabolism at a much higher level than previously assumed.
Keywords: Antibiotic Therapy; Colonic Microflora; Gastrointestinal Function; Gene Expression; Meta-Analysis.
Figures
References
- O'Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep 2006;7:688–93
- Hooper LV, Gordon JI. Commensal host–bacterial relationships in the gut. Science 2001;292:1115–18
- Nicholson JK, Holmes E, Wilson ID. Gut microorganisms, mammalian metabolism and personalized health care. Nat Rev Microbiol 2005,3:431–8
- Turnbaugh PJ, Gordon JI. The core gut microbiome, energy balance and obesity. J Physiol 2006;587:4153–8
- Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010;464:59–65
- Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome. Nature 2011;473:174–80
- Jernberg C, Löfmark S, Edlund C, et al. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 2010;156:3216–3
- Willing BP, Rusell SL, Finlay BB. Shifting the balance: antibiotic effects on host–microbiota mutualism. Nature Rev 2011;9:233–43
- Schmieder R, Edwards R. Insights into antibiotic resistance through metagenomic approaches. Future Microbiol 2012;7:73–89
- Jernberg C, Löfmark S, Edlund C, et al. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J 2007;1:56–66
- Jakobsson HE, Jernberg C, Andersson AF, et al. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PloS One 2010;5:e9836.
- Andersson DI, Hughes D. Persistence of antibiotic resistance in bacterial populations. FEMS Microbiol Rev 2011;35:901–11
- De La Cochetière MF, Durand T, et al. Resilience of the dominant human faecal microbiota upon short-course antibiotic challenge. J Clin Microbiol 2005;43:5588–92
- Dethlefsen L, Huse S, Sogin ML, et al. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 2008;6:e280.
- Antonopoulos DA, Huse SM, Morrison HG, et al. Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun 2009;77:2367–75
- Ubeda C, Taur Y, Jenq RR, et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest 2010;120:4332–41
- Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci USA 2011;105:4554–61
- Turnbaugh PJ, Quince C, Faith JJ, et al. Organismal, genetic, and transcriptional variation in the deeply sequenced gut microbiomes of identical twins. Proc Natl Acad Sci USA 2010;107:7503–8
- Booijink CC, Boekhorst J, Zoetendal EG, et al. Metatranscriptome analysis of the human faecal microbiota reveals subject-specific expression profiles, with genes encoding proteins involved in carbohydrate metabolism being dominantly expressed. Appl Environ Microbiol 2010;76:5533–40
- Gosalbes MJ, Durbán A, Pignatelli M, et al. Metatranscriptomic approach to analyze the functional human gut microbiota. PloS One 2011;6:e17447.
- Klaassens ES, de Vos WM, Vaughan EE. Metaproteomics approach to study the functionality of the microbiota in the human infant gastrointestinal tract. Appl Environ Microbiol 2007;73:1388–92
- Verberkmoes NC, Russell AL, Shah M, et al. Shotgun metaproteomics of the human distal gut microbiota. ISME J 2009;3:179–89
- Rooijers K, Kolmeder C, Juste C, et al. An iterative workflow for mining the human intestinal metaproteome. BMC Genomics 2011;12:6.
- Kolmeder CA, de Been M, Nikkilä J, et al. Comparative metaproteomics and diversity analysis of human intestinal microbiota testifies for its temporal stability and expression of core functions. PloS One 2012;7:e29913.
- Romick-Rosendale LE, Goodpaster AM, Hanwright PJ, et al. NMR-based metabonomics analysis of mouse urine and faecal extracts following oral treatment with the broad-spectrum antibiotic enrofloxacin (Baytril). Magn Reson Chem 2009;47(Suppl 1):S36–6
- Kemp PF, Lee S, Laroche J. Estimating the growth rate of slowly growing marine bacteria from RNA content. Appl Environ Microbiol 1993;59:2594–601
- Moeseneder MM, Arrieta JM, Herndl GJ. A comparison of DNA- and RNA-based clone libraries from the same marine bacterioplankton community. FEMS Microbiol Ecol 2005;51:341–52
- Cole JR, Wang Q, Cardenas E, et al. The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res 2009;37(Database issue):D141–5
- Durbin R, Eddy SR, Krogh A, et al. Biological Sequence Analysis: Probabilistic Models of Proteins and Nucleic Acids. Cambridge, UK: Cambridge University Press, 1998
- Haft DH. The TIGRFAMs database of protein families. Nucleic Acids Res 2003;31:371–3
- Yan J. Som: Self-Organizing Map. R package version 0.3-5. 2010; (accessed 23 November 2012)
- Nakano V, Silva ADNE, Merino VRC, et al. Antimicrobial resistance and prevalence of resistance genes in intestinal Bacteroidales strains. Clinics 2011;66:543–7
- Kristiansson E, Hugenholtz P, Dalevi D. ShotgunFunctionalizeR: an R-package for functional comparisons of metagenomes. Bioinformatics 2009;25:2737–8.
- Barrangou R, Fremaux C, Deveau H, et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science 2007;315:1709–12
- Makarova KS, Grishin NV, Shabalina SA, et al. A putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action. Biol Direct 2006;1:7.
- Ferrer M, Ruiz A, Lanza F, et al. Microbiota from the distal guts of lean and obese adolescents exhibit partial functional redundancy besides clear differences in community structure. Environ MicrobiolPublished Online First 23 Jul 2012.
Source: PubMed